References
- The Information System of the Federal Health Monitoring. Expenditures for Pharmaceuticals. http://www.gbe-bund.de/gbe10/abrechnung.prc_abr_test_logon?p_uid=gast&p_aid=73961465&p_sprache=E&p_knoten=TR19200.
- Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995;155(18):1949–56.
- Thakur R, Hsu SHY, Fontenot G. Innovation in healthcare: issues and future trends. J Bus Res 2012;65(4):562–9.
- Berwick DM. Disseminating innovations in health care. J Am Med Assoc 2003;289(15):1969–75.
- Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q 1989;13(3):319–39.
- Presser S, Rothgeb JM, Couper MP, Lessler JT, Martin E, Martin J, et al.. Methods for testing and evaluating survey questionnaires. 2nd ed. New Jersey: Wiley-Interscience; 2004. p. 528–9.
- Mooi E, Sarstedt M. A concise guide to market research. Heidelberg: Springer; 2011. p. 176–88.
- Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: University Press; 2005.